JTL
DRUG

Jupiter Topco LLC’s Bright Minds Biosciences DRUG Stock Holding History

Jupiter Topco LLC’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.8M Buy
+1,349,107
New +$106M 0.04% 318

Other funds holding DRUG

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Jupiter Topco LLC's DRUG Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in Bright Minds Biosciences (DRUG) in Q2 2026: 1,349,107 shares worth $94.8M. The stake represents 0.04% of the portfolio and ranks #318 among its holdings.

87 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • Jupiter Topco LLC held 1,349,107 shares of Bright Minds Biosciences worth $94.8M as of Q2 2026.
  • Bright Minds Biosciences was a new Jupiter Topco LLC position in Q2 2026.
  • Bright Minds Biosciences made up 0.04% of Jupiter Topco LLC's portfolio in Q2 2026, its #318 holding.
  • 87 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.